Sympathetic neural activity in hypertension and related diseases (Q37774849)

23 August 2017

1 reference

title

Sympathetic neural activity in hypertension and related diseases (English)

1 reference

23 August 2017

arterial hypertension

0 references

author name string

Guido Grassi

series ordinal

1

1 reference

23 August 2017

22 July 2010

1 reference

Journal of Clinical Hypertension

23 August 2017

1 reference

23 August 2017

23

1 reference

23 August 2017

10

1 reference

23 August 2017

1052-1060

1 reference

Sympathetic neural control of integrated cardiovascular function: insights from measurement of human sympathetic nerve activity

23 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

How to assess sympathetic activity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Sympathetic activation in congestive heart failure: reproducibility of neuroadrenergic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Aortic cyclic AMP levels in hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Sympathoadrenal stress reactivity is a predictor of future blood pressure: an 18-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Modulation of blood pressure by central melanocortinergic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Sympathetic-nerve activity during sleep in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Morning blood pressure surge and hypertensive cerebrovascular disease: role of the alpha adrenergic sympathetic nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Catecholamines augment collateral vessel growth and angiogenesis in hindlimb ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Radial artery compliance in response to mental stress in normotensive offspring of hypertensive parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Sympathetic nerve activity in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Subcutaneous obesity is not associated with sympathetic neural activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Sympathetic activity in obese subjects with and without obstructive sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Plasma norepinephrine in congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Effects of Hypertension and Obesity on the Sympathetic Activation of Heart Failure Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Role of nitric oxide in modulating systemic pressor responses to different vasoconstrictors in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Short- and long-term neuroadrenergic effects of moderate dietary sodium restriction in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Internal jugular venous spillover of noradrenaline and metabolites and their association with sympathetic nervous activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Short-versus long-term effects of different dihydropyridines on sympathetic and baroreflex function in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Impact of aldosterone receptor blockade compared with thiazide therapy on sympathetic nervous system function in geriatric hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

2007 Guidelines for the Management of Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

Comparison between reproducibility and sensitivity of muscle sympathetic nerve traffic and plasma noradrenaline in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Renal noradrenaline spillover correlates with muscle sympathetic activity in humans

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Hyperkinetic borderline hypertension in Tecumseh, Michigan

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Sympathoneural and haemodynamic characteristics of young subjects with mild essential hypertension.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Baroreflex control of sympathetic nerve activity in essential and secondary hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Consequences of impaired arterial baroreflexes in essential hypertension: effects on pressor responses, plasma noradrenaline and blood pressure variability.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Relationship between muscle sympathetic nerve activity and diurnal blood pressure profile

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Neurogenic abnormalities in masked hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Left ventricular hypertrophy and sympathetic activity.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Hypertensive left ventricular hypertrophy: relation to peripheral sympathetic drive

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Arterial plasma vasopressin and aldosterone predict left ventricular mass in men who develop hypertension over 20 years

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Sympathetic activation in obese normotensive subjects

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Impact of type 2 diabetes mellitus on sympathetic neural mechanisms in hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Serial Determination of Plasma Catecholamines in Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Prognostic relevance of pathological sympathetic activation after acute thromboembolic stroke

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Physical training and baroreceptor control of sympathetic nerve activity in humans.

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Sympathoexcitatory responses to the acute blood pressure fall induced by central or peripheral antihypertensive drugs

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Sympathetic outflow to muscles during treatment of hypertension with metoprolol

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics

1 reference

https://api.crossref.org/works/10.1038%2FAJH.2010.154

7 January 2021

Identifiers

DOI

10.1038/AJH.2010.154

1 reference

23 August 2017

1 reference

PubMed ID

20651696